Full name
WIELKOPOLSKIE CENTRUM MEDYCYNY PODRÓŻY SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Other research and experimental development on natural sciences and engineering
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
26 - Manufacture of computer, electronic and optical products
58 - Publishing activities
72.11.Z - Research and experimental development on biotechnology
72.20.Z - Research and experimental development on social sciences and humanities
74 - Other professional, scientific and technical activities
75 - Veterinary activities
85 - Education
86 - Human health activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 20,1 | 102,1 | 12 | -88,3 |
EBITDA | 31,2 | 114,5 | 17,5 | -84,7 |
Short time liabilities | 284,1 | 262 | 255,6 | -2,5 |
Equity capital | -162,3 | -129,8 | -119,4 | 8 |
Operating profit (EBIT) | 27,2 | 109,9 | 17,5 | -84,1 |
Assets | 121,8 | 132,2 | 136,2 | 3 |
Net profit (loss) | 17,8 | 102,1 | 10,4 | -89,8 |
Cash | 65,9 | 64,1 | 27,5 | -57 |
Liabilities and provisions for liabilities | 284,1 | 262 | 255,6 | -2,5 |
Net income from sale | 369,3 | 459,7 | 443,4 | -3,5 |
Working assets | 90 | 100,4 | 104,4 | 4 |
Depreciation | 4 | 4,5 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | -11 | -78,7 | -8,7 | 70 |
Equity capital to total assets | -133,2 | -98,2 | -87,7 | 10,5 |
Gross profit margin | 5,5 | 22,2 | 2,7 | -19,5 |
EBITDA Margin | 8,4 | 24,9 | 3,9 | -21 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 281 | 208 | 210 | 2 |
Current financial liquidity indicator | 0.3169175088405609 | 0.3832346498966217 | 0.4084688127040863 | 0 |
Net dept to EBITDA | 6.384424209594727 | 1.7017114162445068 | 11.976576805114746 | 10,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane